Cancer recurrence and the key role of the LSD1 epigenetic enzyme.

    Project: OtherResearch

    Short titleCancer recurrence and the key role of the LSD1 epi
    StatusActive
    Effective start/end date29/06/1629/06/19

    Funding

    • EpiAxis Therapeutics Pty Ltd: AUD337,600.00